Introduction
============

There are few specific early symptoms or sensitive biomarkers for the screening of ovarian cancer. Thus, the majority of patients with ovarian cancer are not diagnosed until stage III--IV when they are no longer eligible for the most effective surgical interventions. Platinum-based chemotherapy has been a critical treatment for ovarian cancer since the late 1970s and has improved overall survival significantly ([@b1-etm-0-0-2833]). However, initial chemotherapy resistance and platinum-resistant relapse occur frequently, causing increased mortality due to progressive disease ([@b2-etm-0-0-2833]). It is therefore imperative to find an approach to overcome resistance to cisplatin (CDDP).

The aquaporins (AQPs) are a family of small transmembrane proteins that primarily facilitate the rapid, passive movement of water or small sugar alcohol molecules, such as glycerol, across cell plasma membranes and are essential for cellular water homeostasis. AQPs are ubiquitously expressed in all types of organisms from bacteria to plants, insects and mammals ([@b3-etm-0-0-2833],[@b4-etm-0-0-2833]). Amino acid sequence and molecular function have been used to categorize AQPs into three distinct subgroups: Classical aquaporins, aquaglyceroporins and unorthodox aquaporins ([@b5-etm-0-0-2833]--[@b8-etm-0-0-2833]). The first group includes AQP0, AQP1, AQP2, AQP4 and AQP5, which have highly selective permeability to water but not other molecules. The aquaglyceroporin group includes AQP3, AQP7, AQP9 and AQP10, which are permeable to water, as well as glycerol, urea and other small non-electrolytes. AQP6, AQP8, AQP11 and AQP12 are classified as unorthodox aquaporins, and their functions remain under investigation ([@b8-etm-0-0-2833]).

It has been revealed that AQPs are unusually expressed in numerous kinds of human cancers. According to the review by Ribatti *et al*, AQP1, AQP3, AQP4, AQP5, AQP8 and AQP9 are closely associated with various kinds of tumors ([@b9-etm-0-0-2833]). In ovarian tumors, the localization and expression patterns of AQP1--9 have been investigated using immunohistochemistry; AQP1, AQP3, AQP5, AQP6, AQP8 and AQP9 were identified in epithelial ovarian cancer, while AQP1, AQP5 and AQP9 were significantly overexpressed in malignant and borderline tumors compared with benign tumors and normal ovarian tissue ([@b10-etm-0-0-2833]). Another study revealed that the expression of AQP1 was not significantly associated with the clinicopathological stage in serous epithelial ovarian cancer ([@b11-etm-0-0-2833]), although AQP1 expression was associated with ascites, intratumoral microvessel density (IMD) and clinicopathological variables. AQP5 is highly expressed in lymph node metastasis cases and in abundant ascites, and previous studies determined that AQP9 expression correlated with the degree of histological malignancy ([@b10-etm-0-0-2833],[@b12-etm-0-0-2833],[@b13-etm-0-0-2833]). It has also been reported that AQP3 facilitates ovarian cancer cell migration and correlates with epidermal growth factor (EGF)-induced cell metastasis ([@b14-etm-0-0-2833]). A previous study by our group demonstrated that CDDP downregulates AQP5 in a concentration-dependent manner in CAOV3 cells, and that nuclear factor (NF)-κB is involved in AQP5 regulation ([@b15-etm-0-0-2833]). Epigallocatechin gallate, which inhibits proliferation and induces apoptosis of SKOV3 cells, decreased the expression of AQP5, suggesting a possible association between ovarian cancer cell proliferation and AQP5 protein expression ([@b16-etm-0-0-2833]). These studies indicate that AQP might be a new therapeutic target for ovarian cancer.

AQPs are involved in the fluidity and integrity of cell membranes, angiogenesis, cell migration and cell volume regulation ([@b9-etm-0-0-2833],[@b17-etm-0-0-2833]). It has been recognized that water transport across cytomembranes could be modified by osmotic stress through AQP proteins, and that an increase in AQP3 or AQP9 expression is associated with increased chemoresistance to arsenite in melanoma, lung cancer, primary cultured chorion and amnion cells ([@b18-etm-0-0-2833]--[@b20-etm-0-0-2833]). AQP expression has also been found to affect chemosensitivity in ovarian carcinoma ([@b21-etm-0-0-2833]), which may be associated with osmosis.

To demonstrate whether chemotherapeutic drug sensitivity and resistance are affected by water permeability and AQP expression in ovarian cancer, the effects of extracellular hyperosmotic stress on AQP expression and sensitivity to CDDP were investigated in the present study.

Materials and methods
=====================

### Cell culture and reagents

Ovarian cancer cell line 3AO was obtained from the Institute of Cancer Research, Chinese Academy of Medical Sciences (Beijing, China). 3AO cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; Gibco BRL, Gaithersburg, MD, USA) supplemented with 15% fetal bovine serum and maintained at 37°C and 5% CO~2~ in a humid environment. For osmotic stress, hyperosmotic medium was made by adding various concentrations of D-sorbitol (Sigma-Aldrich, St. Louis, MO, USA) to regular DMEM for different times. Standard DMEM was used as isosmotic media.

### Cell growth and inhibition rate assay

Cells were treated with the following solutions: i) DMEM medium alone (the control group); ii) 0.625, 1.25, 2.5, 5, 10 or 20 µg/ml CDDP (Sigma-Aldrich) for 24, 48 or 72 h; iii) 100, 200, 300, 400, 500, 600 or 800 mM D-sorbitol for 24, 48 or 72 h; iv) 200 mM D-sorbitol and 0.625, 1.25, 2.5, 5, 10 or 20 µg/ml CDDP for 24, 48 or 72 h. Cell growth and inhibition rate was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.

3AO cells were seeded in 96-well plates (5,000 cells per well) for 24 h and exposed to various concentrations of CDDP or D-sorbitol for 24--72 h. Following treatment, the cells were incubated with 10 µl 5 mg/ml MTT (Sigma-Aldrich) 4 h at 37°C in the dark. The formazan crystals were lysed with 150 µl dimethyl sulfoxide (DMSO; Sigma-Aldrich) for 10 min. Absorbance values (optical density; OD) at a wavelength of 490 nm were obtained using a microplate reader (model 680: Bio-Rad Laboratories, Inc., Hercules, CA, USA). Wells containing cells in DMEM and wells containing no cells served as the normal control and background control, respectively. To convert OD values to a growth inhibition rate, the following equation was used: Inhibition rate = (OD of control -- OD of test concentration)/(OD of control -- OD of cell-free wells). Each concentration was evaluated in 3--5 repeated wells, and every assay was performed at ≥3 times.

### RNA isolation and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

The expression of AQP5 mRNA was examined by RT-qPCR. Total RNA was isolated from 3AO cells with TRIzol reagent (Thermo Fisher Scientific, Inc., Waltham, MA, USA). RNA was quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Inc.). Those samples whose A~260~/A~280~ ratios were 1.8--2.0 were used for further analysis. Then, 1 µg RNA was used for reverse transcription conducted using a PrimeScript™ RT reagent kit with gDNA eraser (Takara Bio, Tokyo, Japan) according to the instructions provided by the manufacturer. qPCR was carried out in a 20-µl reaction volume containing 1 µl cDNA with SYBR Premix Ex Taq™ (Takara Bio) using an Applied Biosystems StepOne Fast Real-Time PCR system (Thermo Fisher Scientific, Inc.). The sequences of the primers used were as follows: AQP1 (NM_198098), sense: 5′-ATC CTC TCA GGC ATC ACC TC-3′ and antisense: 5′-GGT AGT AGCC AGC ACG CAT A-3′; AQP3 (NM_004925), sense: 5′-CAG TGG GAC GTG TTT CTG TC-3′ and antisense: 5′-CCC GGA TCC CTA AGA CTG TA-3′; AQP5 (NM_001651), sense: 5′-CTG TCC ATT GGC CTG TCT GTC-3′ and antisense 5′-GGC TCA TAC GTG CCT TTG ATG-3′; AQP9 (NM_020980), sense: 5′-CCT GAA ACA GCC TTC TCT CC-3′ and antisense: 5′-AAA CCA CCC AAA TGG GAC TA-3′; glyceraldehyde 3-phosphate dehydrogenase (GAPDH), sense: 5′-CAT CAA TGG AAA TCC CATCA-3′ and antisense: 5′-TTCTCCATGGTGGTGAAGAC-3′.

The specificity of primers was tested by running a regular PCR followed by agarose gel electrophoresis. The conditions of the amplification process were: 95°C for 30 sec, 95°C for 5 sec and 60°C for 30 sec, for 45 cycles. Each cDNA sample was analyzed in triplicate, and GAPDH primer was included in every plate as an internal control. Melting curve data were collected to assure PCR specificity. All qPCRs were performed in more than triplicate. Relative quantification of AQP5 mRNA expression was calculated using the 2^−ΔΔCq^ method.

### Western blot analysis

Cells with or without treatments were washed with cold phosphate-buffered saline and harvested by scraping in radioimmunoprecipitation assay (RIPA) buffer containing protease inhibitor cocktail (Sigma-Aldrich). Total protein was extracted with RIPA buffer containing protease inhibitor for 30 min on ice. After centrifugation at 13,000 × g for 15 min at 4°C, protein concentrations were determined by Bio-Rad protein assay (Bio-Rad Laboratories, Inc.). A 40-µg quantity of total protein was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto a polyvinylidene (PVDF) membrane (Millipore, Bedford, MA, USA). After being blocked for 1 h with 5% non-fat milk in Tris-buffered saline and Tween 20 (TBS-T) at room temperature, the membranes were incubated with rabbit polyclonal anti-AQP5 (1:200; BA2200-2; Boster Biological Technology, Wuhan, China) or mouse monoclonal anti-GAPDH (1:5,000; TA-08; Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China) primary antibody at 4°C overnight. The membranes were then washed three times for 10 min each with TBS-T, and incubated with a 1:5,000 dilution of goat anti-rabbit (ZB-5301) or goat anti-mouse (ZB-5305) secondary antibody labeled with horseradish peroxidase (Zhongshan Golden Bridge Biotechnology Co., Ltd.) for 1 h at room temperature. Antibody binding was detected using an enhanced chemiluminescence (ECL; Millipore) detection system following the manufacturer\'s instructions.

### Small interfering (si)RNA transfection

A lentiviral vector (LV) expressing AQP5-siRNA and equipped with green fluorescence protein (GFP) and puromycin acetyltransferase protein (PACP) was constructed by Shanghai GenePharma Co., Ltd. (Shanghai, China). The provided control siRNA was used as a negative control (mock). 3AO cells were transfected with 30 multiplicity of infection (MOI) of AQP5-siRNA in the presence of 6 ng/ml Polybrene (Sigma-Aldrich). The medium containing the siRNA was replaced with fresh medium after 24 h transfection. Green fluorescence was observed after 48 h incubation. Then, cells were screened in medium containing puromycin (3 µg/ml; Sigma-Aldrich) for 3 weeks. Following the selection of transfected 3AO cells, in order to test the effects of AQP5-siRNA, AQP5 expression was detected by RT-PCR and western blotting.

### Statistical analysis

The data are expressed as mean ± standard deviation (SD). Values were analyzed by one-way analysis of variance (ANOVA) and Student\'s unpaired t-test. P\<0.05 was considered to indicate a statistically significant result.

Results
=======

### Effects of hyperosmotic stress on the proliferation of ovarian cancer cells

3AO cells were incubated with various concentrations of D-sorbitol, representing different osmotic pressures, for various times, and the inhibition of cell proliferation was measured by MTT assay. Results showed that 3AO cell proliferation was reduced in a dose- and time-dependent manner in hypertonic culture medium. When 3AO cells were treated with 200 mM D-sorbitol for 24, 48 or 72 h, the inhibition rate of cell proliferation was 10.08, 20.52 and 31.63%, respectively ([Fig. 1](#f1-etm-0-0-2833){ref-type="fig"}).

### Effect of hyperosmotic stress on the mRNA expression of AQPs in ovarian cancer cells

AQP expression is affected by hyperosmotic stress in several cell types. To examine the AQP expression in response to extracellular hyperosmotic stress in ovarian cancer, the mRNA expression levels of various AQPs were measured by RT-qPCR in 3AO cells that were incubated with 50, 100, 200, 300 or 400 mM D-sorbitol (hypertonic medium) for 12, 24 or 48 h. It was found that AQP5 mRNA expression levels increased significantly when the cells were treated with hyperosmotic medium for 24 h. However, AQP5 mRNA expression peaked at the 200 mM concentration of D-sorbitol; at higher concentrations of D-sorbitol, the expression of AQP5 was reduced, yet it remained higher than that in control cultures (P\<0.05; [Fig. 2A](#f2-etm-0-0-2833){ref-type="fig"}). By contrast, the expression levels of AQP1, AQP3 and AQP9 mRNA were only slightly elevated by hypertonic sorbitol-containing medium ([Fig. 2D--F](#f2-etm-0-0-2833){ref-type="fig"}).

When cells were incubated with hypertonic medium for 48 h, the expression levels of AQP1, AQP3, AQP9 mRNA were still only slightly increased ([Fig. 2G--I](#f2-etm-0-0-2833){ref-type="fig"}); however, AQP5 expression was increased continuously and markedly (P\<0.05; [Fig. 2B](#f2-etm-0-0-2833){ref-type="fig"}) as the osmotic pressure increased. To examine the time course of AQP5 expression, 3AO cells were treated with 200 mM D-sorbitol for 12, 24 and 48 h, followed by the analysis of AQP5 mRNA expression levels using RT-qPCR. The outcomes showed that AQP5 mRNA expression was increased in a time-dependent manner in hypertonic medium (P\<0.05; [Fig. 2C](#f2-etm-0-0-2833){ref-type="fig"}). Western blot analysis indicated that post-transcriptional AQP5 expression was induced in a similar manner to transcriptional level expression by hyperosmotic pressure ([Fig. 2J](#f2-etm-0-0-2833){ref-type="fig"}).

### Effects of AQP5 silencing on the response to hyperosmotic stress in 3AO cells

To determine the contribution of AQP5 to hyperosmotic stress, 3AO cells were transfected with LV-siRNA-AQP5 or LV-siRNA-mock siRNA constructs. Transfection efficiency was confirmed by RT-PCR and western blotting ([Fig. 3A and B](#f3-etm-0-0-2833){ref-type="fig"}). MTT assays were performed on transfected cells incubated in D-sorbitol-containing medium for 24 h. The inhibition rate of cell proliferation was significantly increased in cells transfected with AQP5 siRNA compared with that in mock-transfected controls in response to hypertonic medium ([Fig. 3C](#f3-etm-0-0-2833){ref-type="fig"}). The attenuated reactivity of ovarian cancer cells to hyperosmotic pressure increased incrementally with escalating osmotic concentrations in the cells transfected with AQP5 siRNA, which indicated that AQP5 expression facilitated protective mechanisms in response to hypertonic conditions.

### Effect of hyperosmotic stress on cell sensitivity to CDDP

The addition of 200 mM D-sorbitol to the extracellular environment induced hyperosmotic pressure, which elevated AQP5 expression levels and caused slight cytotoxicity ([Figs. 1](#f1-etm-0-0-2833){ref-type="fig"} and [2C](#f2-etm-0-0-2833){ref-type="fig"}). CDDP had variable inhibitory effects on cell proliferation in response to either hypertonic or isotonic conditions. MTT results showed that the inhibition rate of cell proliferation induced by CDDP was increased in extracellular hyperosmotic medium when the CDDP concentration was \<2.5 µg/ml and decreased in hyperosmotic medium with CDDP concentrations of 5--20 µg/ml ([Fig. 4](#f4-etm-0-0-2833){ref-type="fig"}). These results were more pronounced when the incubation time was prolonged to 48 or 72 h. Even though hyperosmosis or CDDP alone can lead to cellular damage, together they exerted an additive effect on cytotoxicity for CDDP concentrations of 0.625 and 1.25 µg/ml. Furthermore, it was found that the decreased sensitivity to CDDP caused by extracellular hyperosmosis at 5 and 10 µg/ml CDDP was significant. In general, the sensitivity of ovarian cancer cells to CDDP was changed by exposure to hypertonic medium. Moreover, CDDP-induced cell death had dose- and time-dependent effects that were independent of a hypertonic or isotonic extracellular environment.

### Effect of hyperosmotic stress on sensitivity to CDDP is associated with AQP5 expression in ovarian tumors

To examine the effect of CDDP on AQP5 expression under conditions of hyperosmotic stress, hyperosmosis was induced by adding 200 mM D-sorbitol to the normal culture medium and treating 3AO cells with increasing concentrations of CDDP (1.25--10 µg/ml) in hypertonic or isotonic medium for 24 h. The RT-qPCR results demonstrated that CDDP had similar effects on AQP5 mRNA expression in hypertonic or isotonic external environments ([Fig. 5A--F](#f5-etm-0-0-2833){ref-type="fig"}). Following a 24-h incubation, a low-dose of CDDP (\<2.5 µg/ml) enhanced AQP5 mRNA expression under hypertonic and isotonic extracellular conditions. At CDDP concentrations ≥5 µg/ml, AQP5 expression was inversely proportional to the CDDP dose, and was reduced compared with that of 2.5 µg/ml CDDP ([Fig. 5A and B](#f5-etm-0-0-2833){ref-type="fig"}). After 48 h of incubation, ≥5 µg/ml CDDP attenuated AQP5 expression levels by a large margin in an isotonic environment when compared with those in the blank cells or the cells treated with 2.5 µg/ml CDDP ([Fig. 5D](#f5-etm-0-0-2833){ref-type="fig"}). However, when cells were treated with CDDP in hypertonic medium for 48 h different consequences were observed, with CDDP at doses ≤2.5 µg/ml inducing intensified AQP5 mRNA expression levels, while AQP5 mRNA expression levels were reduced at CDDP concentrations ≥5 µg/ml compared with those observed for 2.5 µg/ml CDDP ([Fig. 5E](#f5-etm-0-0-2833){ref-type="fig"}). Furthermore, as the incubation time was prolonged, AQP5 expression levels were reduced by CDDP, regardless of whether the extracellular medium was hypertonic or isotonic ([Fig. 5G](#f5-etm-0-0-2833){ref-type="fig"}), and the changes in AQP5 protein expression in response to CDDP were synchronized with those of AQP5 mRNA ([Fig. 5H](#f5-etm-0-0-2833){ref-type="fig"}).

Nevertheless, the primary distinction between the two kinds of extracellular medium was that hyperosmosis enhanced the expression level of AQP5 mRNA at every dose of CDDP tested compared with those in isotonic medium, regardless of whether the incubation time was prolonged (48 h) or not (24 h) ([Fig. 5C and F](#f5-etm-0-0-2833){ref-type="fig"}).

Discussion
==========

Members of the AQP family have been associated with several types of tumors and can affect cell migration, proliferation, and angiogenesis ([@b9-etm-0-0-2833]). AQPs allow water to rapidly penetrate the cell membrane and are the primary determinants of membrane permeability to water. There is evidence that osmotic pressure can modify the expression of AQPs. In MLE-15 mouse lung epithelial cells, AQP5 was induced by hypertonic sorbitol-containing medium ([@b22-etm-0-0-2833],[@b23-etm-0-0-2833]), while in human airway epithelial cells, it was induced by hyperosmotic stress ([@b24-etm-0-0-2833]). AQP5 abundance decreased in a dose-dependent manner when MLE-12 mouse lung epithelial cells were exposed to hypotonic medium ([@b25-etm-0-0-2833]). In human keratinocytes, AQP3 mRNA expression was increased by hypertonic sorbitol-containing medium; however, AQP1, AQP4 and AQP9 mRNA expression remained unchanged ([@b26-etm-0-0-2833]). Moreover, hypertonicity promoted AQP2 expression in mouse principal kidney cortical collecting duct cells ([@b27-etm-0-0-2833]), while hypotonicity reduced it by attenuating cAMP-induced AQP2 promoter activity, a process mediated by TonE-mediated c-Jun N-terminal kinase activation ([@b28-etm-0-0-2833]). In mouse brain tissue, a 3% NaCl hypertonic saline solution inhibited AQP4 mRNA and protein expression in astrocytes ([@b29-etm-0-0-2833]). Despite these results, to the best of our knowledge, AQP expression in response to osmotic stress has not been reported in ovarian cancer.

A previous study reported that AQP1, AQP5 and AQP9 expression levels were significantly increased in malignant ovarian cancer ([@b10-etm-0-0-2833]). In the present study, the effect of hypertonic sorbitol-containing medium on the proliferation of ovarian cancer cells and expression of AQP1, AQP3, AQP5, and AQP9 was determined. The results confirmed that ovarian cancer cell proliferation was dose- and time-dependently inhibited by a hypertonic extracellular environment, and that AQP5 mRNA and protein expression levels were induced by hypertonic stress. This provides the first evidence that AQP mRNA can be induced by hypertonic pressure in epithelial ovarian carcinoma, which is consistent with results in airway epithelial cells ([@b22-etm-0-0-2833]--[@b24-etm-0-0-2833]). Reduced induction of AQP5 by 300 or 400 mM D-sorbitol-containing medium after 24 h could be associated with diminished cell viability at that level of osmotic stress ([@b22-etm-0-0-2833]). However, in the present study, a greater increase in AQP5 mRNA expression was observed with 400 mM sorbitol medium after 48 h. We propose that AQP5 expression can be regulated by osmotic pressure and is associated with cell viability, and the enhancing effects of hypertonic D-sorbitol on AQP5 expression were particularly evident when the incubation time was 48 h.

Previous studies have determined that AQPs are important during membrane osmosis ([@b30-etm-0-0-2833]--[@b32-etm-0-0-2833]). In the current study, the MTT assay results showed that ovarian cancer cells were more susceptible to hypertonic medium after AQP5 expression was reduced by siRNA knockdown. The fact that AQP5 knockdown can reduce both osmotic water permeability and regulatory volume in human lung adenocarcinoma cells ([@b30-etm-0-0-2833]) may explain the effects observed in AQP5-knockdown ovarian cancer cells in response to hyperosmotic pressure. This indicates that AQP5 has an important role in osmotic homeostasis and that hypertonic stress is able to regulate AQP5 expression in ovarian cancer. Therefore, we speculate that ovarian cancer cells adapt to hypertonic pressure based on changes in AQP5 expression, since water permeability is affected by increased AQP5 expression, which allowed the cells to adapt to the extracellular hypertonic state.

The results of the present study also indicated that a D-sorbitol-mediated extracellular hypertonic environment can modify AQP1, AQP3, and AQP9 mRNA expression; however, the changes were not determined to be statistically significant. There are several factors that might explain this result: i) AQP1 is expressed primarily in the microvascular endothelium in ovarian cancer ([@b10-etm-0-0-2833],[@b11-etm-0-0-2833]); ii) AQP3 and AQP9 are aquaglyceroporins permeable to glycerol, urea, other small non-electrolytes and water ([@b8-etm-0-0-2833]); iii) AQP1 and AQP9 are expressed at low levels in 3AO cells ([Fig. 2](#f2-etm-0-0-2833){ref-type="fig"}); and iv) AQPs respond differently to osmotic pressure in various tissues ([@b22-etm-0-0-2833]--[@b29-etm-0-0-2833]).

Our previous study revealed that AQP5 expression was decreased by CDDP in the CAOV3 cell line ([@b15-etm-0-0-2833]), which correlates with the present study, and chemosensitivity was influenced by AQPs in the SKOV3 cell line ([@b21-etm-0-0-2833]). The present study sought to determine the associations among CDDP sensitivity, AQP expression and osmotic pressure in the 3AO cell line. The influence of hyperosmotic pressure on sensitivity to CDDP and its association with the expression of AQP5 is clarified by the current results.

Resistance to CDDP is affected by many factors, including changes in drug uptake and efflux, increased drug metabolism in tumor cells, and DNA repair. Reduced uptake and enhanced efflux of drugs from cells mediated by membrane transporters and ion channels play an important role in drug sensitivity and resistance. Osmotic stress controls water influx and efflux across cells and may have an impact on drug metabolism to further affect drug sensitivity. However, there are few reports that have investigated this mechanism. We have previously demonstrated that hyperosmotic stress induced by sorbitol increases the sensitivity of SKOV3 cells to CDDP ([@b21-etm-0-0-2833]). The present study revealed that sensitivity to CDDP was modified by hypertonic pressure in the 3AO cell line. Moreover, AQP5 expression was modified significantly by hypertonic sorbitol medium and was essential for the response of ovarian cancer cells to extracellular hypertonic medium.

Our results indicate that 3AO cell sensitivity to CDDP is enhanced by extracellular hyperosmosis when the CDDP concentration is low, which may contribute to an induction of CDDP-mediated AQP5 expression, further increased by hypertonic stress. In addition, inhibition of cell proliferation at a high CDDP dose was decreased in hyperosmotic medium compared with that in isotonic medium, and this could be attributed to the downregulation of AQP5 expression caused by a high-dose CDDP being antagonized by hypertonic pressure. Accordingly, we hypothesized that the changes in sensitivity to CDDP induced by hypertonic medium were caused by an increase in AQP5 expression. In addition, the abnormal expression of AQP3 or AQP9 affects chemoresistance to arsenite in melanoma cells, lung cancer, primary cultured chorion and amnion cells ([@b18-etm-0-0-2833]--[@b20-etm-0-0-2833]), and sensitivity to CDDP is associated with AQPs in the SKOV3 cell line ([@b21-etm-0-0-2833]). On the basis of the present study, sensitivity to CDDP is closely associated with AQP5 expression in ovarian cancer. However, additional studies are necessary to determine the association between CDDP sensitivity and AQP5 expression and to elaborate on the regulatory mechanism involved.

In summary, the present study demonstrated that extracellular hypertonic stress inhibits the proliferation of 3AO cells, and that increased expression of AQP5 plays an important role in the response of ovarian cancer cells to hypertonic medium, which regulates CDDP sensitivity in ovarian cancer. Changes in CDDP sensitivity induced by hyperosmosis were found to be associated with changes in AQP5 expression, indicating that AQP5 expression is relevant to CDDP sensitivity. The results show that CDDP sensitivity was affected by extracellular hyperosmosis in an ovarian cancer cell line, which suggests a novel direction for ovarian cancer research. In addition, the important role of AQP5 expression in the regulation of osmotic pressure and sensitivity to chemotherapy suggest it may be a new focus for ovarian cancer-targeted therapy.
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![Cell inhibition rate induced by hypertonic medium. Ovarian cancer cell proliferation was inhibited by hyperosmotic pressure in a concentration- and time-dependent manner. \*P\<0.05, dose group vs time group at mean time.](etm-10-06-2055-g00){#f1-etm-0-0-2833}

![Expression of various AQPs in 3AO ovarian cancer cells in response to hypertonic D-sorbitol medium. AQP5 expression measured by RT-qPCR in 3AO cells that were incubated in isotonic (blank) and hypertonic medium (50--400 mM D-sorbitol) for (A) 24 h or (B) 48 h. (C) AQP5 mRNA expression measured by qRT-PCR in 3AO cells that were treated with 200 mM D-sorbitol for 12, 24 and 48 h. mRNA expression of (D and G) AQP1, (E and H) AQP3 and (F and I) AQP9 detected by qRT-PCR in 3AO cells treated with hypertonic D-sorbitol (50--400 mM) medium and normal medium (blank) for (D-F) 24 h and (G-I) 48 h. (J) AQP5 protein expression determined by western blotting when the cells were cultured with 50--400 mM D-sorbitol medium or regular medium (blank) for 24 h, GAPDH was used as an intrinsic control. \*P\<0.05 vs. blank. AQP, aquaporin; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; B, blank; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.](etm-10-06-2055-g01){#f2-etm-0-0-2833}

![AQP5 was silenced by siRNA. The effects of AQP5 knockdown were examined by (A) RT-qPCR and (B) western blotting. GAPDH was used as an intrinsic control. (C) Cell inhibition rates induced by hypertonic D-sorbitol (100--800 mM) medium were compared by MTT assays of cell viability when AQP5 was knocked down in AO3 ovarian cancer cells. \*P\<0.05 for the AQP5(−) group vs. the mock group. AQP, aquaporin; AQP5(−), AQP5 silenced; siRNA, small interfering RNA; RT-qPCR, reverse transcription-quantitative chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.](etm-10-06-2055-g02){#f3-etm-0-0-2833}

![Changes of sensitivity to CDDP caused by extracellular hyperosmotic stress. 3AO cells were incubated with different concentrations of CDDP (0.625--20 µg/ml) with normal medium or hypertonic medium (200 mM D-sorbitol) for (A) 24 h, (B) 48 h, and (C) 72 h and the cell inhibition rates were compared by MTT assay. Sensitivity to CDDP at concentrations of (D) 1.25 µg/ml, (E) 2.5 µg/ml and (F) 5 µg/ml was decreased in hypertonic medium (200 mM D-sorbitol) compared with that in isotonic medium, regardless of whether the incubation time was 24, 48 or 72 h. \*P\<0.05 CDDP vs. D-sorbitol + CDDP. CDDP, cisplatin; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.](etm-10-06-2055-g03){#f4-etm-0-0-2833}

![AQP5 expression in response to CDDP in hypertonic and isotonic medium in 3AO cells. (A-C) AQP5 expression levels were measured by RT-qPCR when 3AO cells were treated with CDDP in (A) regular medium or (B) 200 mM D-sorbitol medium for 24 h and (C) AQP5 expression levels under the two osmotic conditions were compared. (D-F) treatment time was prolonged to 48 h; AQP5 mRNA expression following treatment with CDDP in (D) isotonic medium or (E) hypertonic medium (200 mM D-sorbitol) and (F) the comparison between them as determined by RT-qPCR. (G) AQP5 mRNA expression levels were decreased by CDDP (expressed in units of µg/ml) in regular medium and hypertonic medium including 200 mM D-sorbitol (200 DS) as the treatment time was extended. (H) AQP5 protein expression levels following treatment with CDDP (0.625--20 µg/ml) in regular medium for 24 and 48 h were measured by western blotting. \*P\<0.05, \*\*P\<0.01. AQP, aquaporin; CDDP, cisplatin; RT-qPCR, reverse transcription-quantitative chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.](etm-10-06-2055-g04){#f5-etm-0-0-2833}
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